| Status | Study |
| Recruiting |
Study Name: Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A Condition: Acquired Hemophilia A Date: 2015-10-29 Interventions: Biological: OBIZUR Treating physician will determine treatment regimen, frequency of laboratory and clin |
| No longer available |
Study Name: Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies Condition: Acquired Hemophilia A Date: 2013-10-21 Interventions: Biological: OBI-1 Other Name: B-Domain Deleted Recombinant Porcine Factor VIII |
| Recruiting |
Study Name: Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa Condition: Haemophilia Date: 2013-05-14 |
| Recruiting |
Study Name: Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study) Condition: Acquired Haemophilia Date: 2012-10-16 Interventions: Drug: Steroid + cyclophosphamide Drug: Ste |
| Completed |
Study Name: Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects Condition: Acquired Bleeding Disorder Acquired Haemophilia Date: 2012-03-21 Interventions: Drug: activated recombinant human factor VII One single dose administration, injected i.v. (into the vei |
| Terminated |
Study Name: Turkish Acquired Haemophilia Registry Condition: Acquired Haemophilia Date: 2011-07-26 Interventions: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin According to local clinical stan |
| Completed |
Study Name: Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia Condition: Acquired Bleeding Disorder Acquired Haemophilia Date: 2011-01-26 Interventions: Drug: activated recombinant human factor VII Data collection of the use of activated recombinant human f |
| Completed |
Study Name: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A Condition: Hemophilia A Date: 2010-08-06 Interventions: Biological: OBI-1 Intravenous infusion |
| Completed |
Study Name: Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany Condition: Congenital Bleeding Disorder Congenital FVII Deficiency Gl Date: 2008-06-11 Interventions: Drug: eptacog alfa (activated) A NON INTERVENTIONAL OBSERV |
| Terminated |
Study Name: Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A Condition: Hemophilia A Date: 2006-03-23 Interventions: Drug: Rituxan Acquired Hemophi |